| Hot New Papers |
ScienceWatch.com |
Mar 2010 |
| Allosteric drugs promise precise control over diseases mediated by G-protein-coupled receptors |
Chemical & Engineering News |
Nov 23, 2009 |
| Leaders in the Study of Allosteric Modulation to Discuss Latest Research at Allosteric and Orthosteric Modulator Congress |
Pharmacology Blogs |
Nov 4, 2009 |
| A New Kind of Drug Target |
Scientific American |
Aug 2009 |
| Targeting M1—The Agony of Agonists, the Power of Potentiators |
Alzheimer Research Forum |
Aug 28, 2009 |
| Adventures in glutamate: The difficult and expensive path of novelty in drug discovery |
In Vivo: The Business & Medicine Report |
Jul/Aug 2009 |
| Vanderbilt Program in Drug Discovery - Fragile X podcast |
VUMC Podcast |
Jul 22, 2009 |
| GPCR Market Exhibits Rapid Diversification |
Genetic Engineering & Biotechnology News |
Oct 15, 2008 |
| Fine-Tuning the Design of GPCR Therapeutics |
Genetic Engineering & Biotechnology News |
Oct 15, 2008 |
| Conn Contributes to Advances in GPCR Webinar .. |
Science |
June 17, 2008 |
| GPCRs Remain “Hot” Drug Targets . |
Genetic Engineering &
Biotechnology News |
May 1, 2008 |
| Study seeks Alzheimer’s disease 'dimmer switch' |
The Reporter |
Jan 18, 2008 |
| A Different Approach to Parkinson's |
The Journal of Life Sciences |
Dec 21, 2007 |
Acetylcholine Boost With a Twist—Compound
Targets M4 Receptors |
Alzheimer Research Forum |
Dec 6, 2007 |
